Our work is focused on the regulation of lipid metabolism, its fatty acid storage and utilisation, and how this may be disturbed in chronic disease states such as cancer, obesity and insulin resistance.
The vision of the Lipid Metabolism Laboratory is to be an innovative, honest, and progressive laboratory that has a drive to make a real impact upon human health.
We have two major research themes:
We aim to improve outcomes for patients living with breast and prostate cancer.
Current treatments are very effective in controlling cancer, but they have major side effects that impact quality of life. Our research will ensure radical treatments can be avoided by developing targeted and durable therapeutic strategies.
By better understanding the influence of these fats on the behaviour of the cancer cells, we will improve the diagnosis of cancer in the short term, enhance current treatments, and develop new treatments in the long term.
Our goal is to make a direct impact on clinical care for cancer patients worldwide.
Our work focuses on several areas:
Medical sciences PhD graduate, Shilpa Nagarajan, has been recognised as a future leader in diabetes and metabolism research, receiving a prestigious postdoctoral fellowship to expand her research into insulin resistance and diabetes.